Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


BAKER BROS. ADVISORS LP Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/10/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Exercised (in-or-at-the-money) 57,049 options to buy @ $0
Exercised (in-or-at-the-money) 535,601 options to buy @ $0
10/05/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 10% stake in Madrigal Pharmaceuticals, Inc.
10/05/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.
Txns: Bought 125,447 warrants @ $0.0001, valued at $12.5
Bought 1,522,651 warrants @ $0.0001, valued at $152.3
10/03/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 554 shares @ $0
10/03/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on INCYTE CORP
Txns: Granted 510 shares @ $0
08/17/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/17/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Bought 143,519 shares @ $0.6308, valued at $90.5k
Bought 1,740,581 shares @ $0.6308, valued at $1.1M
Bought 358 shares @ $0.665, valued at $238.1
Bought 4,342 shares @ $0.665, valued at $2.9k
Bought 17,124 shares @ $0.6805, valued at $11.7k
Bought 207,676 shares @ $0.6805, valued at $141.3k
Bought 366 shares @ $0.6828, valued at $249.9
Bought 4,434 shares @ $0.6828, valued at $3k
Bought 7,676 shares @ $0.6924, valued at $5.3k
Bought 93,091 shares @ $0.6924, valued at $64.5k
Bought 5,041 shares @ $0.6928, valued at $3.5k
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/10/2023 SC 13G/A BAKER BROS. ADVISORS LP reports a 2.2% stake in Mereo BioPharma Group plc
08/10/2023 SC 13G/A BAKER BROS. ADVISORS LP reports a 0% stake in Verastem, Inc.
08/08/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 8.4% stake in Madrigal Pharmaceuticals, Inc.
07/19/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/05/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on Kodiak Sciences Inc.
Txns: Granted 40,000 options to buy @ $6.9, valued at $276k
07/05/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 554 shares @ $0
07/05/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on INCYTE CORP
Txns: Granted 512 shares @ $0
06/28/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 10% stake in IGM Biosciences, Inc.
06/28/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Bought 413,175 options to buy @ $8, valued at $3.3M
Bought 5,211,825 options to buy @ $8, valued at $41.7M
06/16/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on INCYTE CORP
Txns: Granted 2,505 shares @ $0
Granted 11,294 options to buy @ $61.44, valued at $693.9k
Granted 11,294 options to buy @ $61.44, valued at $693.9k
06/12/2023 SC 13G/A BAKER BROS. ADVISORS LP reports a 8% stake in Verastem, Inc.
06/12/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.79, valued at $19.8k
06/08/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 8,746 shares @ $0
Granted 52,472 options to buy @ $15.19, valued at $797k
Granted 52,472 options to buy @ $15.19, valued at $797k
06/05/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Granted 13,304 shares @ $0
Granted 22,090 options to buy @ $23.9, valued at $528k
06/02/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
Granted 2,044 shares @ $0
05/24/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 26.5% stake in ACADIA Pharmaceuticals Inc.
05/24/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Bought 7,645 shares @ $24.4604, valued at $187k
Bought 82,148 shares @ $24.4604, valued at $2M
Bought 3,781 shares @ $24.8, valued at $93.8k
Bought 40,632 shares @ $24.8, valued at $1M
Bought 10,858 shares @ $25.3302, valued at $275k
Bought 116,672 shares @ $25.3302, valued at $3M
Bought 6,941 shares @ $25.54, valued at $177.3k
Bought 74,582 shares @ $25.54, valued at $1.9M
Bought 20,304 shares @ $25.2723, valued at $513.1k
Bought 218,171 shares @ $25.2723, valued at $5.5M
Bought 2,688 shares @ $25.5138, valued at $68.6k
05/24/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 19.5% stake in Prelude Therapeutics Incorporated
05/24/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Granted 121,178 options to buy @ $5.75, valued at $696.8k
Granted 1,327,044 options to buy @ $5.75, valued at $7.6M
Granted 970,220 options to buy @ $0.0001, valued at $97
Granted 10,625,036 options to buy @ $0.0001, valued at $1.1k
05/05/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/05/2023 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
05/05/2023 3 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 3 on BELLICUM PHARMACEUTICALS, INC
05/03/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/06/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 15,500 options to buy @ $12.86, valued at $199.3k
04/04/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on INCYTE CORP
Txns: Granted 429 shares @ $0
Granted 429 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy